巴基斯坦2012-2014年基于实验室的肠热症监测回顾性研究
该研究回顾巴基斯坦3家阿迦汗大学医院2012至2014年住院患者血培养记录,133017份血培养中2872份(2%)阳性,其中伤寒沙门菌1979株(69%)、副伤寒沙门菌893株(31%)。伤寒与副伤寒分离株对氟喹诺酮类耐药均超过90%,伤寒沙门菌多重耐药1035株(52%),副伤寒沙门菌14株(2%),未见死亡报告;作者认为高耐药水平与疾病严重程度支持继续监测并改进诊断。
要点
- 133017份血培养中2872份(2%)阳性,伤寒沙门菌1979株(69%)、副伤寒沙门菌893株(31%)。
- 伤寒与副伤寒分离株对氟喹诺酮类耐药均超过90%,几乎无头孢菌素类耐药。
- 多重耐药见于1035株(52%)伤寒沙门菌与14株(2%)副伤寒沙门菌,未见死亡报告。
核心结论
- 作者认为高抗菌药物耐药水平与疾病严重程度的证据支持继续开展伤寒监测并改进诊断。
- 作者提出需在巴基斯坦开展进一步前瞻性研究,评估疫苗接种作为肠热症预防工具的作用,以指导疾病干预策略。
主要发现
- 研究期间共完成133017份血培养,2872份(2%)阳性,其中伤寒沙门菌1979份(69%)、副伤寒沙门菌893份(31%)。
- 伤寒沙门菌与副伤寒沙门菌分离株中氟喹诺酮类耐药均超过90%,几乎无分离株对头孢菌素类耐药。
- 多重耐药(对氨苄西林、氯霉素和复方磺胺甲噁唑耐药)见于1035株(52%)伤寒沙门菌分离株和14株(2%)副伤寒沙门菌分离株。
- 伤寒沙门菌与副伤寒沙门菌分离株中666株(23%)对应有病历的住院患者;537例住院伤寒沙门菌病例中280例(52%)年龄5-15岁、133例(25%)2-4岁、114例(21%)大于15岁、10例(2%)0-1岁;129例住院副伤寒沙门菌病例中73例(57%)大于15岁、41例(32%)5-15岁、13例(10%)2-4岁、2例(2%)0-1岁。
- 伤寒沙门菌与副伤寒沙门菌病例在恶心呕吐、腹泻、食欲减退和头痛方面观察到症状学显著差异;肠热症病例最常见报告的并发症为白细胞减少、血小板减少和脑病,未见死亡报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Surveillance for Enteric Fever in Asia Project (SEAP) is a multisite surveillance study designed to capture morbidity and mortality burden of enteric fever (typhoid and paratyphoid) in Bangladesh, Nepal, and Pakistan. We aim to describe enteric fever disease burden, severity of illness, and antimicrobial resistance trends in Pakistan. METHODS: In this retrospective, cross-sectional study, laboratory records of hospitalized patients who received a blood culture in any of 3 Aga Khan University hospitals in Karachi and Hyderabad, Pakistan, from 2012 to 2014 were reviewed. A case was defined as having a positive blood culture for Salmonella Typhi (S. Typhi) or Salmonella Paratyphi (S. Paratyphi). Antimicrobial sensitivity patterns were characterized for all S. Typhi and S. Paratyphi isolates. Medical records were available for abstraction (demographics, clinical features, complications) only among hospitalized cases. RESULTS: Of the 133017 blood cultures completed during the study period, 2872 (2%) were positive-1979 (69%) for S. Typhi and 893 (31%) for S. Paratyphi. Fluoroquinolone resistance was present in >90% of both the S. Typhi and the S. Paratyphi isolates; almost none of the isolates were resistant to cephalosporins. Multidrug resistance (resistance to ampicillin, chloramphenicol, and cotrimoxazole) was observed in 1035 (52%) S. Typhi isolates and 14 (2%) S. Paratyphi isolates. Among S. Typhi and S. Paratyphi isolates, 666 (23%) were linked to hospitalized patients with medical records. Of the 537 hospitalized S. Typhi cases, 280 (52%) were aged 5-15 years, 133 (25%) were aged 2-4 years, 114 (21%) were aged >15 years, and 10 (2%) were aged 0-1 years. Among the 129 hospitalized S. Paratyphi cases, 73 (57%) were aged >15 years, 41 (32%) were aged 5-15 years, 13 (10%) were aged 2-4 years, and 2 (2%) were aged 0-1 years. Significant differences in symptomology between S. Typhi and S. Paratyphi cases were observed for nausea/vomiting, diarrhea, loss of appetite, and headache. Leukopenia, thrombocytopenia, and encephalopathy were the most commonly reported complications among enteric fever cases. No deaths were reported. CONCLUSION: Evidence of high antimicrobial resistance levels and disease severity support the need for continued surveillance and improved diagnostics for typhoid. Further prospective studies on vaccination as a tool for prevention of enteric fever in Pakistan are needed to inform disease intervention strategies.
引用
- Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014. J Infect Dis. 2018. PMID: 30060168. doi:10.1093/infdis/jiy205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。